do you have knowledge about this investigational drug - RaphaLX.
they seem pretty confident in this drug
" RaphaLX™ is the company's flagship product that has been granted Orphan Drug Designation (ODD) by the FDA to treat ALS (amyotropic lateral sclerosis). It is a breakthrough formulation derived from human gut bacteria (microbiome), which in human studies has been observed to slow down the progression of the disease and in certain cases reverse the condition"
and I found this :
they seem pretty confident in this drug
" RaphaLX™ is the company's flagship product that has been granted Orphan Drug Designation (ODD) by the FDA to treat ALS (amyotropic lateral sclerosis). It is a breakthrough formulation derived from human gut bacteria (microbiome), which in human studies has been observed to slow down the progression of the disease and in certain cases reverse the condition"
and I found this :

Comment